ACR 2022 Congress Highlights Webinar
21st November 2022
With the continued release of new treatment data in RA, axSpA, and PsA, this webinar will highlight the key data presented at ACR 2022. This session will review the latest safety and efficacy data of JAK inhibitors as well as the impact on clinical practice and patient outcomes. Join us and get your cytokine signalling updates from ACR 2022.
- Leonard Calabrese (Chair): RA: A Therapeutic Update
- Laura Coates: The Modern World of PsA Treatment
- Sofia Ramiro: The Latest Advances in axSpA